-
1 Comment
Fuji Pharma Co., Ltd is currently in a long term downtrend where the price is trading 8.9% below its 200 day moving average.
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Fuji Pharma Co., Ltd's total revenue rose by 3.6% to $9B since the same quarter in the previous year.
Its net income has increased by 78.3% to $1B since the same quarter in the previous year.
Based on the above factors, Fuji Pharma Co., Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3816200004 |
| Beta | 0.25 |
|---|---|
| Target Price | 2150 |
| PE Ratio | 7.53 |
| Dividend Yield | 3.3% |
| Market Cap | 33B |
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4554.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
